Emerald’s Endo Omega Vegan, the First Omega Supplement Formulated to Support the Endocannabinoid System, Takes Home Top Honor
San Diego, CA, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Emerald Health Bioceuticals (“Emerald”), a leading innovator of nutritional supplements that support the human endocannabinoid system (ECS), announced today that its latest product, Endo Omega Vegan, has received the prestigious 2019 NEXTY "Best New Supplement" award at the Natural Products Expo East in Baltimore, MD.
The NEXTY Awards, sponsored by New Hope Network and judged by a team of 8 industry experts, recognize excellence in products that demonstrate innovation, integrity, and inspiration to advance the natural products industry and deliver trusted health products to consumers.
Unlike traditional omega supplements, Endo Omega Vegan is emulsified for enhanced absorption and bioavailability, making its 100% natural Cafe Mocha flavor uniquely creamy and delicious straight off the spoon. It is entirely free of animal products, herbicides, pesticides, artificial colors or flavors, and GMOs.
"While CBD is one of the hottest health trends today, what is less well known is that we produce our very own cannabinoids, called “endo” cannabinoids, that are many times more potent and effective at maintaining optimal health and happiness,” said Jade Beutler, CEO, Emerald. "Our body requires dietary essential fatty acids as nutritional building blocks to 'grow its own' endocannabinoids, and Endo Omega has been formulated to provide these essential fatty acids in the precise amounts and ratios to do just that."
Endo Omega is the latest addition to Emerald’s lineup of award-winning condition-specific products formulated to address consumers' principal health concerns (sleep, inflammation, stress, mood, immune and brain health) by supporting the endocannabinoid system without the use of cannabis or its derivatives.
Emerald’s products can be found in Whole Foods Market nationwide, on Amazon.com, and in over 1,300 retail health food stores across the country. They are also available in Canada through Emerald Health Naturals, Emerald’s joint venture with Emerald Health Therapeutics (TSX:V EMH; OTCQX: EMHTF).
Please visit emeraldhealthbio.com for more information.
About the Nexty Awards
NEXTY Awards are a twice-annual award connected to New Hope Network's Natural Products Expo shows in March and September. They were created to recognize the most game-changing and inspiring products in the natural/organic CPG market today. Products are nominated and winners are chosen through a two-tier judging process by the New Hope Network content team and a panel of industry judges. Learn more about the NEXTY awards at expowest.com/nexty. Additionally, the five Editor's Choice winners are chosen from the exhibitors at Expo East by the New Hope content team.
About Emerald Health Bioceuticals
Emerald Health Bioceuticals is a global leader in the research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). The ECS is a biological system that plays a vital role in the orchestration, maintenance, and balance of human health and well-being. Emerald’s nutritional supplements activate the endocannabinoid system through its proprietary PhytoCann® Complex, which is formulated with non-cannabis herbal and botanical cannabinoids that may favorably impact the ECS. The over-the-counter product line includes: Endo Sleep, Endo Inflame, Endo Brain, Endo Bliss, Endo Calm, Endo Immune and Endo Omega. Emerald is part of the Emerald Group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.
###
Media Contact: Matt Kovacs
mkovacs@blazepr.com
www.emeraldhealthbio.com